You can buy or sell CYTH and other stocks, options, and ETFs commission-free!
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product candidates include Trappsol Cyclo, which treats Neimann-Pick Type C disease. The firm focuses on the development and commercialization of innovative cyclodextrin-based products for the treatment of people with serious and life threatening rare diseases and medical conditions. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL. The listed name for CYTH is Cyclo Therapeutics, Inc. Common Stock.
Nathan Scott Fine
52 Week High
52 Week Low